Laura Rozenblum, Fatima-Zohra Mokrane, Randy Yeh, Mathieu Sinigaglia, Florent L Besson, Romain-David Seban, Charline Zadro, Lawrence Dierickx, Cecile N Chougnet, Ephraim Partouche, Paul Revel-Mouroz, Binsheng Zhao, Philippe Otal, Lawrence H Schwartz, Laurent Dercle
The majority of gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are diagnosed at a non-resectable stage due to non-specific clinical syndromes, late manifestations from mass effects, or incidental detection of a clinically silent disease. Management strategies include curative or cytoreduction surgery, imaging-guided intervention, chemotherapy, immunotherapy, and radionuclide therapies. In this step-by-step review, we provide a structured approach for standardized reading and reporting of medical imaging studies covering content and terminology...
January 2020: European Journal of Radiology